In this article, we review the childhood outcomes of neonates with birth depression and/or
hypoxic-ischemic encephalopathy. The outcomes of these children prior to the era of …

Objective To evaluate the safety and short-term outcomes of preterm neonates born at 34-35
weeks gestation with hypoxic-ischemic encephalopathy (HIE) treated with therapeutic …

Moderate to severe hypoxic–ischemic injury in newborn infants, manifested as
encephalopathy immediately or within hours after birth, is associated with a high risk of …

Therapeutic hypothermia is now the standard of care for brain injury control in term infants
with perinatal hypoxic ischemic encephalopathy (HIE). Accumulated evidence shows a …

Objective To review developmental outcomes of neonates with mild hypoxic-ischemic
encephalopathy (HIE) treated with therapeutic hypothermia (TH). Study Design Neonates≥ …

There is now a strong evidence base supporting therapeutic hypothermia for infants with
moderate or severe neonatal hypoxic ischaemic encephalopathy. Experimental and clinical …

Hypoxic-ischemic encephalopathy (HIE) is the most common cause of neonatal
encephalopathy with a global incidence of approximately 1 to 8 per 1,000 live births …

Abstract Purpose of Review Therapeutic hypothermia reduces death or disability in term and
near-term infants with moderate-severe hypoxic-ischemic encephalopathy. Nevertheless …

Opinion statement Neonatal Hypoxic-ischemic encephalopathy in full term infants has been
associated with a high risk for morbidity and mortality. The patho-physiology of brain injury …

Background Therapeutic hypothermia reduces the risk of death, or moderate to severe
neurodevelopmental impairment (NDI) in term infants with hypoxic-ischemic …